Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Early Experience With Teprotumumab for Chronic Thyroid Eye Disease
source: American Journal of Ophthalmology Case Reports
year: 2020
authors: Daniel J.Ozzello, Don O.Kikkawa, Bobby S.Kornab
summary/abstract:Purpose:
To report the first case of a patient with chronic thyroid eye disease (TED) treated with teprotumumab.
Observations:
A 50-year-old female with a 3-year history of Graves’ disease presented with bilateral exophthalmos greatest on the left side. She was followed for 2 years with stable proptosis measurements (23mm OD, 28mm OS). Her clinical activity score (CAS) was 1 and there were no examination findings reflective of active inflammation. The patient underwent systemic treatment with teprotumumab and despite chronic TED and low CAS, she had notable improvement in proptosis (18mm OD, 22mm OS) and decrease in extraocular muscle volume as noted on orbital imaging.
Conclusion and Importance:
This case report suggests that teprotumumab may be used in patients with chronic TED and low CAS. Improvement in the proptosis and reduction in extraocular muscle volume suggest that teprotumumab may alter disease course even in patients with inactive or quiescent TED.
DOI: 10.1016/j.ajoc.2020.100744
read more
myBinderRelated Content
-
Quality of Life Remains Poor in People With Thyroid Eye Diseasehttps://www.youtube.com/watch?v=fwYlJ_pt...
-
FDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
-
Catherine J. Hwang, MDDr. Catherine J. Hwang was born in New Y...
-
Graves’ Orbitopathy as a Rare Disease in Europe: A European Group on Graves’ Orbitopathy (EUGOGO) Positi...Background: Graves' orbitopathy (GO) is...
-
Therapy of Endocrine Disease: Endocrine Dilemma: Management of Graves’ OrbitopathyManagement of Graves' orbitopathy (GO) m...
-
University of Minnesota – Center for Thyroid Eye DiseaseIf you experience dry or watery eyes, re...
-
National Survey for Those Living With Thyroid Eye Disease (TED)Horizon Therapeutics is conducting a nat...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google